{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:52:02Z","timestamp":1793659922282,"version":"4.5.1"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T00:00:00Z","timestamp":1648512000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Aims of the study<\/jats:title><jats:p>To analyze the prevalence of self-reported anxiety and depression in a monocentric cohort of patients with Systemic Lupus Erythematosus (SLE); to study the main determinants and the impact on quality of life (QoL).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A cross-sectional observational study including adult outpatients with SLE. Demographic and clinical data were analyzed: indices of disease activity (SELENA-SLEDAI); damage (SLICC-DI); comorbidities and concomitant therapies. The definitions for remission (DORIS) and \u201cLupus Low Disease Activity State\u201d (LLDAS) were applied. At enrollment, each patient completed the following questionnaires: SF-36, FACIT-Fatigue, Lupus Impact Tracker (LIT), Systemic Lupus Activity Questionnaire (SLAQ), and the Hospital Anxiety and Depression Scale (HADS) in order to self-assess anxiety and depression symptoms. The Student <jats:italic>t<\/jats:italic>-test and Chi<jats:sup>2<\/jats:sup> tests were conducted for univariate analysis. The Spearman test was used for linear correlation between continuous data. Multivariate analysis was performed by multiple linear and logistic regression.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>One hundred fifty-four consecutive patients with SLE were enrolled, the majority female and Caucasian with a mean age = 43.3 \u00b1 13.7 years. 79.9% were in LLDAS or remission. 36.4% had a SDI &amp;gt; 1. 13.7% of patients had concomitant fibromyalgia. 37.4% had symptoms indicating anxiety and 25% of depression according to the HADS questionnaire. In the multivariate analysis, patients with active disease were significantly more anxious and depressed (<jats:italic>p<\/jats:italic> &amp;lt; 0.01) compared to patients in LLDAS or remission. Fibromyalgia and older age were independently associated with anxiety and depression, respectively (<jats:italic>p<\/jats:italic> &amp;lt; 0.05). Active skin involvement was significantly linked to depression (<jats:italic>p<\/jats:italic> &amp;lt; 0.05). Higher scores on the HADS questionnaire (higher levels of anxiety and depression) were found to be significantly linked to patients\u2019 perception of higher disease activity and worse quality of life, irrespective of disease activity, age and fibromyalgia.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Symptoms of anxiety and depression are frequent in SLE patients, including outpatients with mild\/moderate disease. Such symptoms have a significant negative impact on QoL and perception of disease activity, regardless of other factors. Moreover, disease activity, advanced age and fibromyalgia appear to be significantly linked to mood disorders. Assessing symptoms of the anxious-depressive spectrum in patients with SLE could lead to improvement in patients\u2019 perception of health status and quality of life.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2022.859840","type":"journal-article","created":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T04:14:22Z","timestamp":1648613662000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["Self-Reported Anxiety and Depression in a Monocentric Cohort of Patients With Systemic Lupus Erythematosus: Analysis of Prevalence, Main Determinants, and Impact on Quality of Life"],"prefix":"10.3389","volume":"9","author":[{"given":"Elena","family":"Elefante","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Tani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Stagnaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viola","family":"Signorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Lenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Zucchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Trentin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Carli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Ferro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Mosca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.3899\/jrheum.080214","article-title":"Changing patterns in mortality and disease outcomes for patients with systemic lupus erythematosus.","volume":"35","author":"Urowitz","year":"2008","journal-title":"J Rheumatol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.berh.2013.07.009","article-title":"Fatigue, health-related quality of life and other patient-reported outcomes in systemic lupus erythematosus.","volume":"27","author":"Schmeding","year":"2013","journal-title":"Best Pract Res Clin Rheumatol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.rdc.2009.12.006","article-title":"Health-related quality of life and employment among persons with systemic lupus erythematosus.","volume":"36","author":"Yazdany","year":"2010","journal-title":"Rheum Dis Clin North Am."},{"key":"B4","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1177\/0961203306071710","article-title":"A review of health related quality of life in systemic lupus erythematosus.","volume":"15","author":"McElhone","year":"2006","journal-title":"Lupus."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1177\/0961203308094280","article-title":"Risk and predictors of work disability in Chinese patients with systemic lupus erythematosus.","volume":"17","author":"Mok","year":"2008","journal-title":"Lupus."},{"key":"B6","doi-asserted-by":"publisher","first-page":"993","DOI":"10.4088\/JCP.11r07425","article-title":"Psychiatric symptoms in systemic lupus erythematosus: a systematic review.","volume":"73","author":"Meszaros","year":"2012","journal-title":"J Clin Psychiat."},{"key":"B7","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1002\/art.22881","article-title":"Development and validation of a disease-specific health-related quality of life measure, the LupusQol, for adults with systemic lupus erythematosus.","volume":"57","author":"McElhone","year":"2007","journal-title":"Arthritis Rheum."},{"key":"B8","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1177\/0961203313477227","article-title":"Depression and systemic lupus erythematosus: a systematic review.","volume":"22","author":"Palagini","year":"2013","journal-title":"Lupus."},{"key":"B9","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1136\/annrheumdis-2016-209519","article-title":"A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS).","volume":"76","author":"van Vollenhoven","year":"2017","journal-title":"Ann Rheum Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1136\/annrheumdis-2015-207726","article-title":"Definition and initial validation of a Lupus Low Disease Activity State (LLDAS).","volume":"75","author":"Franklyn","year":"2016","journal-title":"Ann Rheum Dis."},{"key":"B11","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale.","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr Scand."},{"key":"B12","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.semarthrit.2019.03.004","article-title":"Assessment of the psychometric properties of patient-reported outcomes of depression and anxiety in systemic lupus erythematosus.","volume":"49","author":"Kwan","year":"2019","journal-title":"Semin Arthritis Rheum."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1007\/s00296-017-3819-x","article-title":"Assessment of the Hospital Anxiety and Depression Scale (HADS) performance for the diagnosis of anxiety in patients with systemic lupus erythematosus.","volume":"37","author":"de Almeida Mac\u00eado","year":"2017","journal-title":"Rheumatol Int."},{"key":"B14","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.semarthrit.2019.06.017","article-title":"Prevalence and metric of depression and anxiety in systemic lupus erythematosus: a systematic review and meta-analysis.","volume":"50","author":"Moustafa","year":"2020","journal-title":"Semin Arthritis Rheum."},{"key":"B15","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1002\/art.24519","article-title":"Prevalence of mood and anxiety disorders in women with systemic lupus erythematosus.","volume":"61","author":"Bachen","year":"2009","journal-title":"Arthritis Rheum."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1177\/0961203315591026","article-title":"Active disease is independently associated with more severe anxiety rather than depressive symptoms in patients with systemic lupus erythematosus.","volume":"24","author":"Tay","year":"2015","journal-title":"Lupus."},{"key":"B17","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1177\/0961203317722412","article-title":"Discordance of patient and physician health status concerns in systemic lupus erythematosus.","volume":"27","author":"Golder","year":"2018","journal-title":"Lupus."},{"key":"B18","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s13075-020-02334-5","article-title":"Articular involvement, steroid treatment and fibromyalgia are the main determinants of patient-physician discordance in systemic lupus erythematosus.","volume":"22","author":"Elefante","year":"2020","journal-title":"Arthritis Res Ther."},{"key":"B19","doi-asserted-by":"publisher","first-page":"3211","DOI":"10.1093\/rheumatology\/keaa098","article-title":"Association between depression and anxiety with skin and musculoskeletal clinical phenotypes in systemic lupus erythematosus.","volume":"59","author":"Eldeiry","year":"2020","journal-title":"Rheumatology."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e000113","DOI":"10.1136\/lupus-2015-000113","article-title":"Factors associated with pain coping and catastrophising in patients with systemic lupus erythematosus: a cross-sectional study of the LuLa-cohort.","volume":"2","author":"Fischin","year":"2015","journal-title":"Lupus Sci Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/bjd.14868","article-title":"A systematic review of patient-reported outcomes in patients with cutaneous lupus erythematosus.","volume":"176","author":"Ogunsanya","year":"2017","journal-title":"Br J Dermatol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s40257-019-00429-7","article-title":"Chronic cutaneous lupus erythematosus: aepression burden and associated factors.","volume":"20","author":"Hong","year":"2019","journal-title":"Am J Clin Dermatol."},{"key":"B23","first-page":"S40","article-title":"Fibromyalgia prevalence and related factors in a large registry of patients with systemic lupus erythematosus.","volume":"34","author":"Torrente-Segarra","year":"2016","journal-title":"Clin Exp Rheumatol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1093\/rheumatology\/keh392","article-title":"Health-related quality of life in Italian patients with systemic lupus erythematosus. II. Role of clinical, immunological and psychological determinants.","volume":"43","author":"Doria","year":"2004","journal-title":"Rheumatology."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1177\/0961203311412097","article-title":"The Patient Reported Outcomes in Lupus (PATROL) study: role of depression in health-related quality of life in a Southern California lupus cohort.","volume":"20","author":"Moldovan","year":"2011","journal-title":"Lupus."},{"key":"B26","first-page":"389","article-title":"Association of depressive\/anxiety symptoms with quality of life and work ability in patients with systemic lupus erythematosus.","volume":"34","author":"Mok","year":"2016","journal-title":"Clin Exp Rheumatol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/acr.24398","article-title":"Major depression and adverse patient-reported outcomes in systemic lupus erythematosus: aesults from a prospective longitudinal cohort.","volume":"73","author":"Dietz","year":"2021","journal-title":"Arthritis Care Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1177\/0961203317751858","article-title":"Illness perception is significantly determined by depression and anxiety in systemic lupus erythematosus.","volume":"27","author":"Nowicka-Sauer","year":"2018","journal-title":"Lupus."},{"key":"B29","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.comppsych.2015.09.004","article-title":"Illness perception in systemic lupus erythematosus patients: the roles of alexithymia and depression.","volume":"63","author":"Barbasio","year":"2015","journal-title":"Compr Psychiat."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.859840\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T04:14:26Z","timestamp":1648613666000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.859840\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,29]]},"references-count":29,"alternative-id":["10.3389\/fmed.2022.859840"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.859840","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,29]]},"article-number":"859840"}}